TY - JOUR
T1 - CORONARY ATHEROSCLEROSIS SCORING BY THE LEIDEN CCTA RISK SCORE FOR PREDICTION OF MAJOR ADVERSE CARDIAC EVENTS
T2 - The American College of Cardiology 68th Annual Scientific Sessions
AU - van den Hoogen, Inge J.
AU - van Rosendael, Alexander
AU - Lin, Fay
AU - Achenbach, Stephan
AU - Al-Mallah, Mouaz H.
AU - Budoff, Matthew
AU - Berman, Daniel
AU - Cademartiri, Filippo
AU - Chang, Hyuk Jae
AU - Chow, Benjamin
AU - Cury, Ricardo
AU - Feuchtner, Gudrun
AU - Hadamitzky, Martin
AU - Hausleiter, Joerg
AU - Kaufmann, Philipp A.
AU - Leipsic, Jonathon
AU - Kim, Yong Jin
AU - Marques, Hugo
AU - Pontone, Gianluca
AU - Raff, Gilbert
AU - Rubinshtein, Ronen
AU - Villines, Todd
AU - Min, James
AU - Bax, Jeroen J.
N1 - Publisher Copyright:
© 2019 American College of Cardiology Foundation
PY - 2019/3/12
Y1 - 2019/3/12
N2 - Background: Risk scores derived from general populations of patients with chest pain often do not apply well to patients with diabetes mellitus (DM). To evaluate the performance of the Leiden coronary computed tomography angiography (CCTA) risk score—which incorporates many dimensions of coronary atherosclerosis—in diabetic and non-diabetic patients. Methods: 2,900 DM patients with suspected or known CAD underwent CCTA. In total, 732 diabetics were 1:1 propensity-matched with 732 non-diabetics by age, gender and cardiovascular risk factors. Leiden CCTA risk score (range 0-42) was compared between groups, along with per-patient and per-segment scores based on plaque composition, stenosis and location. Cox-regression analysis was used to assess the association between the Leiden CCTA risk score and the primary endpoint of all-cause death and non-fatal myocardial infarction. Results: In the study population (58 ± 12 years, 40% female), events occurred in 95 diabetics and 60 non-diabetics after median follow-up of 5.1 years. The Leiden CCTA risk score and per-patient weight scores were significantly higher in diabetic patients (all p<0.001). The Leiden CCTA risk score was independently predictive of the endpoint in DM and non-DM patients, especially when categorized (Figure 1, all p<0.05). Importantly, the interaction between DM and the score was non-significant (p>0.05). Conclusion The Leiden CCTA risk score applies well in both DM and non-DM patients, and may be useful for risk stratification.
AB - Background: Risk scores derived from general populations of patients with chest pain often do not apply well to patients with diabetes mellitus (DM). To evaluate the performance of the Leiden coronary computed tomography angiography (CCTA) risk score—which incorporates many dimensions of coronary atherosclerosis—in diabetic and non-diabetic patients. Methods: 2,900 DM patients with suspected or known CAD underwent CCTA. In total, 732 diabetics were 1:1 propensity-matched with 732 non-diabetics by age, gender and cardiovascular risk factors. Leiden CCTA risk score (range 0-42) was compared between groups, along with per-patient and per-segment scores based on plaque composition, stenosis and location. Cox-regression analysis was used to assess the association between the Leiden CCTA risk score and the primary endpoint of all-cause death and non-fatal myocardial infarction. Results: In the study population (58 ± 12 years, 40% female), events occurred in 95 diabetics and 60 non-diabetics after median follow-up of 5.1 years. The Leiden CCTA risk score and per-patient weight scores were significantly higher in diabetic patients (all p<0.001). The Leiden CCTA risk score was independently predictive of the endpoint in DM and non-DM patients, especially when categorized (Figure 1, all p<0.05). Importantly, the interaction between DM and the score was non-significant (p>0.05). Conclusion The Leiden CCTA risk score applies well in both DM and non-DM patients, and may be useful for risk stratification.
UR - http://www.scopus.com/inward/record.url?scp=85187967451&partnerID=8YFLogxK
U2 - 10.1016/S0735-1097(19)32056-X
DO - 10.1016/S0735-1097(19)32056-X
M3 - Conference article
AN - SCOPUS:85187967451
SN - 0735-1097
VL - 73
SP - 1450
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 9
Y2 - 16 March 2019 through 18 March 2019
ER -